Akebia Therapeutics | Spese Operative

Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Adcock Ingram Holdings ZAR 3.91B 168.42M 2023-06
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Akebia Therapeutics USD 54.82M 260K 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Ardelyx USD 48.99M 10.04M 2023-09
Astellas Pharma JPY 386.93B 57.73B 2023-09
AstraZeneca USD 9.54B 578M 2023-09
Avrobio USD 22.93M 90.94M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Celltrion KRW 367.44B 38.37B 2023-12
Cspc Pharmaceutical CNY 5.83B 288.16M 2023-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Ecofibre AUD 19.41M 20.67M 2023-06
Exelixis USD 489.5M 97.5M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Ironwood Pharmaceuticals USD 79.96M 6.25M 2023-12
J&J USD 16.57B 435M 2023-12
Kangmei Pharma CNY 1.18B 120.88M 2023-09
Knight Therapeutics CAD 79.21M 9.9M 2023-09
Laboratorios Farma EUR 295.57M 10.33M 2023-06
Lexicon Pharmaceuticals USD 49.79M 5.24M 2023-09
Magenta Therapeutics USD 16.68M 9.31M 2023-09
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 29.84M 359K 2023-06
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neuren Pharmaceuticals AUD 14.78M 6.84M 2023-06
Organigram Holdings CAD 252.42M 202.16M 2023-03
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pharma Mar EUR 37.64M 4.52M 2023-09
Probiotec AUD 99.23M 4.08K 2023-06
PTC Therapeutics USD 438.79M 124.05M 2023-12
Qiagen NV USD 378.71M 10.71M 2023-09
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Sartorius EUR 730.7M 24.1M 2023-09
Sino Biopharmaceutical CNY 11.53B 892.53M 2023-06
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06
Zz Pientze Pharmaceu 1.52B 25.23M 2023-09



Akebia Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.